Preliminary open-label experience with topiramate in primary generalized seizures.


Preliminary data concerning the effectiveness of topiramate (TPM) in the management of resistant primary generalized seizures were obtained from the open-label extension of a double-blind, placebo-controlled trial of TPM. The controlled trial enrolled patients experiencing three or more primary generalized tonic-clonic seizures (PGTCS) during an 8-week… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.